Abstinence News and Research RSS Feed - Abstinence News and Research

Abstinence is a voluntary restraint from indulging a desire or appetite for certain bodily activities that are widely experienced as giving pleasure. Most frequently, the term refers to abstention from sexual intercourse, alcohol or food. The practice can arise from religious prohibitions or practical considerations.
Month-long residential program helps young adults stay drug-free

Month-long residential program helps young adults stay drug-free

Residential treatment may be an appropriate first-line option for young adults who are dependent on opioid drugs - including prescription painkillers and heroin - and may result in higher levels of abstinence than does the outpatient treatment that is currently the standard of care. [More]
Small financial incentives double smoking cessation rates, study reveals

Small financial incentives double smoking cessation rates, study reveals

Offering small financial incentives doubles smoking cessation rates among socioeconomically disadvantaged smokers, according to research from The University of Texas Health Science Center at Houston. [More]
Effective treatment for sleep disturbance may lower risk of drug and alcohol relapse recovery

Effective treatment for sleep disturbance may lower risk of drug and alcohol relapse recovery

Insomnia is a "prevalent and persistent" problem for patients in the early phases of recovery from the disease of addiction—and may lead to an increased risk of relapse, according to a report in the November/December Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine. [More]
Researchers identify genetic markers that play role in alcoholism recovery

Researchers identify genetic markers that play role in alcoholism recovery

In an international study, Mayo Clinic researchers and collaborators have identified genetic markers that may help in identifying individuals who could benefit from the alcoholism treatment drug acamprosate. The findings, published in the journal Translational Psychiatry, show that patients carrying these genetic variants have longer periods of abstinence during the first three months of acamprosate treatment. [More]
Researchers find potential target for therapies to treat cocaine addiction

Researchers find potential target for therapies to treat cocaine addiction

A study led by investigators from Massachusetts General Hospital and the Perelman School of Medicine at the University of Pennsylvania has identified a potential target for therapies to treat cocaine addiction. [More]
Teen binge drinking effects may last a lifetime, suggests UMass Amherst study

Teen binge drinking effects may last a lifetime, suggests UMass Amherst study

Binge drinking can have lasting effects on brain pathways that are still developing during adolescence, say neuroscience researcher Heather N. Richardson and her colleagues at the University of Massachusetts Amherst and Louisiana State University. [More]
New research may help identify individuals at increased risk of pancreatic cancer

New research may help identify individuals at increased risk of pancreatic cancer

New research that provides a better understanding of pancreatic cancer may help identify individuals at increased risk. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society. [More]
Ampro Industries spreads HIV/AIDS awareness through "A Positive Message" campaign

Ampro Industries spreads HIV/AIDS awareness through "A Positive Message" campaign

It is well known that Ampro Industries, Inc., is a leader when it comes to giving back to the community. The company truly believes in going the extra mile for those who have kept their styling gels number one for decades. [More]
E-cigarettes fail to help cancer patients give up smoking

E-cigarettes fail to help cancer patients give up smoking

In a new study of cancer patients who smoke, those using e-cigarettes (in addition to traditional cigarettes) were more nicotine dependent and equally or less likely to have quit smoking traditional cigarettes than non-users. [More]
Research to determine whether messages about drinking provide clear warnings

Research to determine whether messages about drinking provide clear warnings

Alcohol industry magazine ads reminding consumers to "drink responsibly" or "enjoy in moderation" fail to convey basic public health information, according to a new study from the Johns Hopkins Bloomberg School of Public Health. [More]
Researchers focus on how exposure to opioids may alter expression of OPRM1 gene

Researchers focus on how exposure to opioids may alter expression of OPRM1 gene

Some infants born with neonatal abstinence syndrome (NAS) secondary to in-utero opioid exposure have a more difficult time going through withdrawal than others, but the underlying reasons are not well understood. [More]
Postdischarge intervention helps smokers quit smoking

Postdischarge intervention helps smokers quit smoking

Among hospitalized adult smokers who wanted to quit, a postdischarge intervention that included automated telephone calls and free medication resulted in higher sustained smoking cessation rates at six months than standard postdischarge advice to use smoking cessation medication and counseling, according to a study in the August 20 issue of JAMA. [More]
Potential health concerns, but limited data on electronic cigarettes safety

Potential health concerns, but limited data on electronic cigarettes safety

Electronic cigarettes (ECIGs) are booming in popularity-but there's still only limited evidence on their potential health risks, or their advertised benefits in helping people to quit smoking, according to a research review in the July/August Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine. [More]
States grapple with mental illness issues; Oregon moves closer to limiting Medicaid patients' access to new hepatitis C drugs

States grapple with mental illness issues; Oregon moves closer to limiting Medicaid patients' access to new hepatitis C drugs

The numbers, posted daily on the Cook County sheriff's website, would be alarming at an urgent care clinic, let alone a jail: On a Wednesday, 36 percent of all new arrivals report having a mental illness. On a Friday, it's 54 percent. But inside the razor wire framing the 96-acre compound, the faces and voices of the newly arrested confirm its accidental role as Chicago's treatment center of last resort for people with serious mental illnesses (Geller, 7/14). [More]
Kaleo announces U.S. availability of EVZIO for emergency treatment of opioid overdose

Kaleo announces U.S. availability of EVZIO for emergency treatment of opioid overdose

Kaleo, a privately-held pharmaceutical company headquartered in Richmond, Virginia, today announced the United States (U.S.) commercial availability of EVZIO for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. [More]
Combining NRT with varenicline improves smoking abstinence

Combining NRT with varenicline improves smoking abstinence

Combining the smoking cessation medication varenicline with nicotine replacement therapy was more effective than varenicline alone at achieving tobacco abstinence at 6 months, according to a study in the July 9 issue of JAMA. [More]
Alcoholic liver disease: an interview with Dr Vinood Patel, University of Westminster

Alcoholic liver disease: an interview with Dr Vinood Patel, University of Westminster

Alcoholic liver disease (ALD) is one of the leading causes of death worldwide and also in the UK. As its name indicates this disease arises due to consuming excessive amounts of alcohol (80 g/day) over an extended period, normally 10-20 years. [More]
State highlights: Ohio managed care plans launch; Bluecross Blueshield plan faces Ore. lawsuit; N.Y. policy on unvaccinated children upheld

State highlights: Ohio managed care plans launch; Bluecross Blueshield plan faces Ore. lawsuit; N.Y. policy on unvaccinated children upheld

A selection of health policy stories from Ohio, Oregon, New York, Colorado, Iowa, New Jersey, North Carolina, Georgia, California and Minnesota. [More]
XenoPort initiates XP23829 Phase 2 clinical trial in patients with psoriasis

XenoPort initiates XP23829 Phase 2 clinical trial in patients with psoriasis

XenoPort, Inc. announced today that it has initiated a Phase 2 clinical trial of XP23829, its proprietary investigational next-generation fumaric acid product candidate. The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of XP23829 as a potential treatment of patients with moderate-to-severe chronic plaque-type psoriasis. [More]
Special issue explores trends related to unmet need for contraception

Special issue explores trends related to unmet need for contraception

Studies in Family Planning, a leading journal published by the Population Council, released "Unmet Need for Family Planning"-a special issue featuring ten articles, including a comprehensive introduction to the topic of unmet need. [More]